Meeting
2021 ASCO Annual Meeting
Impact of multidisciplinary severe immunotherapy complication service on outcomes for cancer patients receiving immune checkpoint inhibition.
Authors
Leyre Zubiri
Massachusetts General Hospital, Boston, MA
Leyre Zubiri , Gabriel E. Molina , Meghan Mooradian , Sienna Durbin , Michael Dougan , Molly Thomas , Alexander Faje , Michelle Rengarajan , Amanda C Guidon , Steven T. Chen , Mazen Nasrallah , Minna Kohler , Meghan Sise , Tomas G Neilan , Daniel A Zlotoff , Aditya Bardia , Ryan J. Sullivan , Yevgeniy R. Semenov , Alexandra C Villani , Kerry Lynn Reynolds
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Other IO-Related Topics
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 2654)
DOI
10.1200/JCO.2021.39.15_suppl.2654
Abstract #
2654
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Quality Care Symposium
Daily rounds on inpatient oncology floor by inpatient hospitalist oncologist and reduced length of stay.
First Author: Sabeen Fatima Mekan
Poster
2024 ASCO Annual Meeting
Trend and burden of cancer related hospitalizations in the US: Insights from a National Inpatient Sample Database analysis.
First Author: Rohit Singh
Poster
2022 ASCO Annual Meeting
Reducing oncology readmissions through a multidisciplinary discharge approach.
First Author: Samantha DiBenedetto
Poster
2022 ASCO Annual Meeting
Analysis of incidence/mortality/cost for thrombotic events in hospitalized patients with lung cancer using the National Inpatient Sample database.
First Author: Kuldeepsinh Atodaria